FRANKFURT (dpa-AFX) - Deutsche Bank Research has raised its target price for Schott Pharma from 38 to 42 euros ahead of the quarterly figures and left its rating at "Buy". In a study published on Thursday, analyst Falko Friedrichs expects a decent first quarter for the pharmaceutical supplier. He forecasts an increase of 6 percent for the operating result (adjusted EBITDA) and 3 percent for organic sales growth./edh/gl

Publication of the original study: 15.02.2024 / Time not specified in study / CET First dissemination of the original study: 15.02.2024 / 06:45 / CET

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------